- call +1-201-465-4211
- email sales@mrinsights.biz
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Scope of the Report:
This report focuses on the Opioids Agonist Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
The worldwide market for Opioids Agonist Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 23800 million US$ in 2023, from 18600 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Market Segment by Applications, can be divided into
Pain Management
Cough Treatment
Diarrhea Treatment
There are 15 Chapters to deeply display the global Opioids Agonist Drugs market.
Chapter 1, to describe Opioids Agonist Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Opioids Agonist Drugs, with sales, revenue, and price of Opioids Agonist Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioids Agonist Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Opioids Agonist Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Codeine
1.2.2 Fentanyl
1.2.3 Meperidine
1.2.4 Methadone
1.2.5 Morphine
1.2.6 Hydrocodone
1.3 Market Analysis by Applications
1.3.1 Pain Management
1.3.2 Cough Treatment
1.3.3 Diarrhea Treatment
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Purdue Pharma
2.1.1 Business Overview
2.1.2 Opioids Agonist Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Titan pharmaceuticals
2.2.1 Business Overview
2.2.2 Opioids Agonist Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Opioids Agonist Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Janssen Pharmaceuticals, Inc
2.4.1 Business Overview
2.4.2 Opioids Agonist Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Opioids Agonist Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sun Pharmaceuticals
2.6.1 Business Overview
2.6.2 Opioids Agonist Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mallinckrodt Pharmaceuticals
2.7.1 Business Overview
2.7.2 Opioids Agonist Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Egalet Corporation
2.8.1 Business Overview
2.8.2 Opioids Agonist Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Endo Pharmaceuticals Inc.
2.9.1 Business Overview
2.9.2 Opioids Agonist Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Allergan, Plc
2.10.1 Business Overview
2.10.2 Opioids Agonist Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer Inc
2.11.1 Business Overview
2.11.2 Opioids Agonist Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Opioids Agonist Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Opioids Agonist Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Opioids Agonist Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Opioids Agonist Drugs Market Analysis by Regions
4.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Agonist Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.5 South America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5 North America Opioids Agonist Drugs by Countries
5.1 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6 Europe Opioids Agonist Drugs by Countries
6.1 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.3 UK Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.4 France Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Opioids Agonist Drugs by Countries
7.1 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.5 India Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8 South America Opioids Agonist Drugs by Countries
8.1 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Opioids Agonist Drugs by Countries
9.1 Middle East and Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioids Agonist Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Opioids Agonist Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
10 Global Opioids Agonist Drugs Market Segment by Type
10.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Opioids Agonist Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2013-2018)
10.2 Codeine Sales Growth and Price
10.2.1 Global Codeine Sales Growth (2013-2018)
10.2.2 Global Codeine Price (2013-2018)
10.3 Fentanyl Sales Growth and Price
10.3.1 Global Fentanyl Sales Growth (2013-2018)
10.3.2 Global Fentanyl Price (2013-2018)
10.4 Meperidine Sales Growth and Price
10.4.1 Global Meperidine Sales Growth (2013-2018)
10.4.2 Global Meperidine Price (2013-2018)
10.5 Methadone Sales Growth and Price
10.5.1 Global Methadone Sales Growth (2013-2018)
10.5.2 Global Methadone Price (2013-2018)
10.6 Morphine Sales Growth and Price
10.6.1 Global Morphine Sales Growth (2013-2018)
10.6.2 Global Morphine Price (2013-2018)
10.7 Hydrocodone Sales Growth and Price
10.7.1 Global Hydrocodone Sales Growth (2013-2018)
10.7.2 Global Hydrocodone Price (2013-2018)
11 Global Opioids Agonist Drugs Market Segment by Application
11.1 Global Opioids Agonist Drugs Sales Market Share by Application (2013-2018)
11.2 Pain Management Sales Growth (2013-2018)
11.3 Cough Treatment Sales Growth (2013-2018)
11.4 Diarrhea Treatment Sales Growth (2013-2018)
12 Opioids Agonist Drugs Market Forecast (2018-2023)
12.1 Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Opioids Agonist Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.2 Europe Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.4 South America Opioids Agonist Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Opioids Agonist Drugs Market Forecast (2018-2023)
12.3 Opioids Agonist Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Opioids Agonist Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Opioids Agonist Drugs Market Share Forecast by Type (2018-2023)
12.4 Opioids Agonist Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Opioids Agonist Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Opioids Agonist Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Opioids Agonist Drugs Picture
Table Product Specifications of Opioids Agonist Drugs
Figure Global Sales Market Share of Opioids Agonist Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
